By Counterforce Health Team in Opsumit (macitentan) —

How to Get Opsumit (Macitentan) Covered by Cigna in Virginia: Complete Coding and Appeal Guide

Answer Box: Fast Track to Opsumit Coverage in Virginia

Getting Opsumit (macitentan) approved by Cigna in Virginia requires prior authorization with proper coding and clinical documentation. Submit PA using ICD-10 codes I27.0 (primary PAH) or I27.21 (secondary PAH), NDC 0078-0661-01, and right heart catheterization results showing WHO Group 1 PAH. If denied, you have 180 days for internal appeals and 120 days for Virginia external review through the State Corporation Commission Bureau of Insurance (1-877-310-6560). Start today: Call Cigna at the number on your member ID card to request prior authorization forms, or have your doctor submit through the provider portal.

Table of Contents

  1. Coding Basics: Medical vs. Pharmacy Benefit Paths
  2. ICD-10 Mapping for PAH
  3. Product Coding: HCPCS, NDC, and Units
  4. Clean Prior Authorization Anatomy
  5. Frequent Coding Pitfalls
  6. Verification with Cigna Resources
  7. Appeals Playbook for Virginia
  8. Quick Audit Checklist
  9. FAQ

Coding Basics: Medical vs. Pharmacy Benefit Paths

Opsumit (macitentan) typically falls under pharmacy benefits with Cigna, managed through Express Scripts. However, understanding both pathways helps ensure proper billing:

Pharmacy Benefit (Most Common):

  • Primary NDC: 0078-0661-01 (10 mg tablets, 60-count)
  • Requires prior authorization through Express Scripts
  • Dispensed via specialty pharmacies like Accredo
  • Standard copay/coinsurance applies after PA approval

Medical Benefit (Less Common):

  • HCPCS J8499 (oral non-chemotherapeutic drug, NOS)
  • Used when administered in clinical settings
  • Requires separate medical PA process
  • May apply to buy-and-bill scenarios
Note: Most Cigna members will use the pharmacy benefit pathway. Verify your specific plan's coverage by calling the customer service number on your ID card.

ICD-10 Mapping for PAH

Accurate diagnosis coding is critical for Opsumit approval. Virginia's external review process emphasizes proper clinical documentation, making ICD-10 precision essential.

Primary Codes for PAH

ICD-10 Code Description Documentation Requirements
I27.0 Primary pulmonary hypertension (idiopathic PAH) Right heart catheterization, no underlying cause identified
I27.21 Secondary pulmonary arterial hypertension RHC + additional codes for underlying conditions

Supporting Documentation Language

Your medical records should include these key phrases to support ICD-10 coding:

  • "WHO Group 1 pulmonary arterial hypertension"
  • "Mean pulmonary artery pressure >20 mmHg"
  • "Pulmonary capillary wedge pressure ≤15 mmHg"
  • "Pulmonary vascular resistance ≥3 Wood units"
  • "WHO functional class [I-IV]"

When using I27.21, include additional codes for associated conditions:

  • Congenital heart disease (Q20-Q28)
  • HIV disease (B20)
  • Portal hypertension (K76.6)
  • Collagen vascular disease
  • Drug or toxin-induced PAH

Product Coding: HCPCS, NDC, and Units

NDC and Billing Units

Primary NDC: 0078-0661-01

  • Strength: 10 mg tablets
  • Package size: 60-count bottle
  • Billing unit: 1 tablet = 1 unit
  • Typical daily dose: 10 mg once daily (1 unit per day)

HCPCS Coding (Medical Benefit)

When billed under medical benefits:

  • HCPCS: J8499 (Prescription drug, oral, non-chemotherapeutic, NOS)
  • Units: Based on daily supply (30-day supply = 30 units for 10 mg daily)
  • Modifiers: May require modifier indicating specialty drug status

Pregnancy Testing Requirements

Following FDA removal of the REMS program, Opsumit still requires:

  • Negative pregnancy test before initiation for females of reproductive potential
  • Ongoing contraception counseling and monitoring
  • Immediate discontinuation if pregnancy detected
  • Monthly monitoring recommended during treatment
Tip: The simplified post-REMS process makes prescribing easier, but embryo-fetal toxicity warnings remain in effect.

Clean Prior Authorization Anatomy

A successful Opsumit PA request includes these essential elements:

Required Clinical Information

  1. Diagnosis confirmation: ICD-10 code with supporting RHC results
  2. WHO functional class: Document current functional status (I-IV)
  3. Prior therapies: List previous PAH treatments, outcomes, and reasons for discontinuation
  4. Contraindications: Note any allergies or contraindications to alternative ERAs
  5. Dosing rationale: Justify 10 mg daily dosing per FDA labeling

Supporting Documentation

  • Right heart catheterization report
  • Echocardiogram results
  • Pulmonary function tests
  • 6-minute walk test results (if available)
  • Previous treatment records showing failures or intolerances

Submission Process

Cigna requires PA for Opsumit with approval typically granted for 12 months. Submit via:

  • Cigna provider portal (preferred)
  • Fax using Cigna General Medication PA Form
  • Phone: Express Scripts at 1-844-374-7377 (24/7)

Frequent Coding Pitfalls

Common Mistakes That Delay Approval

1. Wrong ICD-10 Selection

  • Using I27.9 (unspecified pulmonary hypertension) instead of specific PAH codes
  • Missing secondary condition codes when using I27.21

2. Incomplete Functional Class Documentation

  • Failing to document WHO functional class
  • Using NYHA instead of WHO classification for PAH

3. NDC/Unit Conversion Errors

  • Calculating units incorrectly for 30-day vs. 90-day supplies
  • Using wrong NDC for different strengths

4. Missing REMS Documentation

  • Although REMS is discontinued, some older forms may still reference it
  • Ensure current pregnancy testing documentation is included

Quick Fixes

  • Always verify current ICD-10 codes before submission
  • Double-check unit calculations (10 mg daily = 30 units for 30-day supply)
  • Use most recent Cigna PA forms (verify dates)
  • Include WHO functional class in all submissions

Verification with Cigna Resources

Before submitting your PA request, verify these key elements:

Check Current Formulary Status

  1. Log into myCigna member portal
  2. Search "Opsumit" or "macitentan" in drug lookup
  3. Verify tier status and PA requirements
  4. Note any quantity limits or step therapy requirements

Confirm PA Requirements

  • Review current Cigna PA policy for ERAs
  • Check for updates to clinical criteria
  • Verify required documentation list

Provider Resources

  • Access Cigna provider portal for current forms
  • Use PrescriberPoint for payer-specific PA forms
  • Confirm submission methods (portal vs. fax)

Appeals Playbook for Virginia

If Cigna denies your Opsumit request, Virginia provides a robust appeals process with specific timelines and protections.

Internal Appeals (Required First Step)

Level Deadline Decision Timeline Process
First-Level 180 days from denial 30 days (72 hours expedited) Submit additional clinical evidence
Second-Level After first denial 30 days (72 hours expedited) Independent physician review

Virginia External Review

After exhausting Cigna's internal process, you can file for external review:

Timeline: 120 days from Cigna's final denial Process: File Form 216-A with Virginia SCC Bureau of Insurance Cost: Free for Virginia residents Decision: 45 days standard (72 hours expedited) Contact: 1-877-310-6560

Virginia Advantage: The external review decision is binding on Cigna, and many specialty drug denials are overturned when proper clinical evidence is provided.

When to Request Expedited Review

Your physician can request expedited appeals when:

  • Delays could jeopardize your life or health
  • You're currently on Opsumit and facing interruption
  • Rapid disease progression is documented

Quick Audit Checklist

Before submitting your Opsumit PA request, verify:

Clinical Documentation:

  • Right heart catheterization results included
  • Correct ICD-10 code (I27.0 or I27.21 with secondary codes)
  • WHO functional class documented
  • Prior therapy failures documented
  • Pregnancy test results (if applicable)

Coding Accuracy:

  • Correct NDC: 0078-0661-01
  • Accurate unit calculation for days supply
  • Appropriate HCPCS if medical benefit
  • Current Cigna PA form used

Submission Details:

  • Complete prescriber information
  • Patient demographics match insurance
  • Clinical rationale clearly stated
  • Supporting documents attached

Follow-up Plan:

  • PA tracking number obtained
  • Follow-up date scheduled
  • Appeal strategy prepared if denied

About Counterforce Health: At Counterforce Health, we help patients and clinicians navigate complex prior authorization and appeals processes. Our platform analyzes denial letters and creates targeted, evidence-backed appeals that speak directly to payer policies. When you're facing an Opsumit denial from Cigna, having the right clinical evidence and procedural knowledge can make the difference between approval and ongoing delays.

For Virginia patients specifically, understanding both Cigna's internal requirements and Virginia's external review process creates multiple pathways to coverage. The key is proper preparation and knowing which clinical evidence resonates with each level of review.

FAQ

How long does Cigna PA take for Opsumit in Virginia? Standard PA decisions take 72 hours (2 business days) once complete documentation is received. Expedited reviews are decided within 24 hours when medical urgency is certified.

What if Opsumit is non-formulary on my Cigna plan? You can request a formulary exception by demonstrating that preferred alternatives are ineffective or contraindicated. The process uses the same PA forms but requires additional justification for non-preferred status.

Can I get expedited appeals in Virginia? Yes, both Cigna internal appeals and Virginia external reviews offer expedited timelines (72 hours) when your physician certifies that delays could jeopardize your health.

Does step therapy apply if I've tried ERAs outside Virginia? Treatment history from other states counts toward step therapy requirements, but you'll need to provide documentation of prior trials and outcomes from your previous providers.

What counts as medical necessity for Opsumit? Medical necessity requires documented WHO Group 1 PAH diagnosis with right heart catheterization, appropriate functional class, and either failure of or contraindications to preferred alternatives.

How much does Virginia external review cost? Virginia external review is completely free for residents. There are no filing fees or administrative costs.

What happens if I win my Virginia external review? Cigna must provide coverage within 1-3 days of an overturned denial. For expedited reviews, authorization must occur within 24 hours.

Can my doctor submit the PA for me? Yes, prescribers can submit PA requests directly through Cigna's provider portal or by calling Express Scripts at 1-844-374-7377.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage decisions depend on individual plan benefits and clinical circumstances. Always consult with your healthcare provider and insurance plan for specific guidance. For assistance with Virginia insurance appeals, contact the State Corporation Commission Bureau of Insurance at 1-877-310-6560.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.